SIH Partners LLLP Purchases New Holdings in Stryker Co. (NYSE:SYK)

SIH Partners LLLP purchased a new position in shares of Stryker Co. (NYSE:SYK - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 3,000 shares of the medical technology company's stock, valued at approximately $1,080,000.

A number of other hedge funds and other institutional investors have also modified their holdings of SYK. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Stryker in the fourth quarter worth about $25,000. Rakuten Securities Inc. lifted its holdings in Stryker by 618.2% in the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock worth $28,000 after purchasing an additional 68 shares during the last quarter. Centricity Wealth Management LLC acquired a new stake in Stryker in the 4th quarter worth approximately $30,000. BankPlus Trust Department bought a new stake in Stryker during the fourth quarter worth approximately $33,000. Finally, Activest Wealth Management bought a new position in shares of Stryker in the fourth quarter valued at approximately $36,000. Institutional investors own 77.09% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on SYK shares. Barclays raised their target price on shares of Stryker from $418.00 to $443.00 and gave the company an "overweight" rating in a research note on Monday, February 10th. Citigroup reaffirmed a "buy" rating and issued a $450.00 price target on shares of Stryker in a research report on Wednesday, February 26th. Royal Bank of Canada boosted their price objective on Stryker from $425.00 to $435.00 and gave the stock an "outperform" rating in a research report on Wednesday, January 29th. JPMorgan Chase & Co. increased their target price on Stryker from $420.00 to $445.00 and gave the company an "overweight" rating in a research note on Wednesday, January 29th. Finally, Stifel Nicolaus lifted their price target on Stryker from $400.00 to $440.00 and gave the stock a "buy" rating in a research report on Wednesday, January 29th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, Stryker presently has a consensus rating of "Moderate Buy" and a consensus price target of $423.53.

Insiders Place Their Bets

In related news, Director Allan C. Golston sold 2,458 shares of the firm's stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total transaction of $941,586.06. Following the sale, the director now directly owns 14,895 shares in the company, valued at $5,705,827.65. This trade represents a 14.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Ronda E. Stryker sold 201,392 shares of the stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $392.24, for a total value of $78,993,998.08. Following the transaction, the director now owns 3,642,075 shares of the company's stock, valued at approximately $1,428,567,498. This trade represents a 5.24 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 5.20% of the company's stock.

Stryker Price Performance

Stryker stock traded up $3.83 during trading hours on Thursday, hitting $360.94. 1,349,722 shares of the stock were exchanged, compared to its average volume of 1,356,480. Stryker Co. has a 12 month low of $314.93 and a 12 month high of $406.19. The business's 50-day moving average is $368.21 and its two-hundred day moving average is $373.06. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.32 and a current ratio of 1.95. The stock has a market capitalization of $137.77 billion, a P/E ratio of 46.51, a P/E/G ratio of 2.93 and a beta of 0.93.

Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, beating analysts' consensus estimates of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter in the previous year, the business posted $3.46 earnings per share. Equities research analysts expect that Stryker Co. will post 13.47 EPS for the current fiscal year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be paid a $0.84 dividend. The ex-dividend date of this dividend is Monday, March 31st. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.93%. Stryker's dividend payout ratio (DPR) is presently 43.30%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.